adrenoceptor antagonist drugs department of pharmacology zhu ling ( 朱玲 ) 2010.3

19
Adrenoceptor antagonist Adrenoceptor antagonist drugs drugs Department of pharmacology Zhu ling ( 朱朱 ) 2010.3

Upload: nathaniel-davidson

Post on 17-Dec-2015

233 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

Adrenoceptor antagonist drugsAdrenoceptor antagonist drugs

Department of pharmacology

Zhu ling (朱玲 )

2010.3

Page 2: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

Adrenoceptor antagonist drugsAdrenoceptor antagonist drugs

Adrenoceptor antagonist drugs ( Adrenoceptor blocking drugs )

A kind of drugs that can combine to adrenoreceptor and have little or no mimic action of NA , but prevent the receptor activation by adrenergic transmitter and related agonist.

According to receptor selectivity, it can be classified to three groups.

Page 3: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

Adrenoceptor antagonist drugsAdrenoceptor antagonist drugs groups drugs

αreceptor antagonist

α1 α2 R antagonist phentolamine phenoxybenzamine

α1 R antagonist Prazosin, terazosin

α2 R antagonist yohimbine

β receptor antagonist

β1 β2 R antagonist Propranolol, timolol, pindolol

β1 R antagonist Atenolol, metoprolol

β2 R antagonist butoxamine

αβ receptor antagonist labetalol

Page 4: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

αreceptor antagonistαreceptor antagonist αreceptor antagonist may be reversible or irreversible

in their inter action with these receptor. classification : short-duration group phentolamine 酚妥拉明 tolazoline 妥拉唑啉 Prazosin and analogs

reversible antagonists

long-duration group phenoxybenzamine酚苄明 irreversible antagonist

Page 5: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3
Page 6: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

αreceptor antagonistαreceptor antagonisteffect

1 blood vessels and blood pressure

block α receptor

direct relaxes blood vessels muscle

vasodilation blood pressure

epinephrine reversal

2 heart reflex cardiac stimulation

presynapseα2 R blocking , negative feedback

Page 7: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3
Page 8: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3
Page 9: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

αreceptor antagonistαreceptor antagonist

3 others cholinomimetic and histamine-like effect (short-duration agents)

blocking Ach, histamine and serotonin (5-HT) receptors ( phenoxybenzamine )

Page 10: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

αreceptor antagonistαreceptor antagonist

Therapeutic application :① peripheral vascular disease (raynaud’s

disease)② inadvertent infiltration of NA into

subcutaneous during intravenous administration

③ shock cardiac stimulation④ prostate hyperplasia⑤ preoperative management of patients with

pheochromocytoma ⑥ hypertensive emergencies

Page 11: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

αreceptor antagonistαreceptor antagonist

Adverse reaction :① prostural hypotension

② reflex tachycardia, arrhythmia

③ diarrhea, gastrointestinal stimulation, etc

Page 12: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β β receptor antagonistreceptor antagonist

A kind of drugs share the common feature of antagonizing the effects of catecholamine at βadrenoceptors, high selectivity occupy β adrenoceptors and competitively reduce receptor occupancy by catecholamines and other βagonists.

pure antagonist partial antagonist

Page 13: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β receptor antagonistβ receptor antagonistthe process in the bodythe process in the body

high lipid-solubility low lipid-solubility

Propranolol metoprolol timolol

Atenolol pindolol nadolol acebutolol

Well absorption Limited absorption

Low bioavailability No obviously first-pass elimination

Half life short Half life long

Plasma concentrations: great individual variability

Plasma concentrations: relatively invariableness

hepatic metabolism Excreted unchanged in the urine

Page 14: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β β receptor antagonistreceptor antagonistPharmacodynamics1 β blockade effects

1) heart inhibition

2) blood vessels peripheral resistance↑

3) blood pressure chronically lower

β blockade – reduce cardiac output

presynaptic membranes β blockade effects

CNS β blockade effects

antagonize the release of renin

Page 15: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

Adrenoceptor antagonist drugsAdrenoceptor antagonist drugs

Page 16: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

4) bronchia smooth muscles contraction 5) metabolism inhibit sympathtic nervous system stimulation

of lipolysis , partially inhibit glycogenolysis (impair

recovery from hypoglycemia, great caution in insulin-dependent diabetic patients)

anti-hyperthyroid renin release decrease

β receptor antagonist

Page 17: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β β receptor antagonistreceptor antagonist

2 Intrinsic sympathomimetic activity(ISA)

except blockade effect, it has partial agonistic action

3 else

local anesthetic action (membrane-stabilizing action)

anti-platelet congregate

Page 18: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β receptor antagonistβ receptor antagonist Therapeutic application 1 cardiac arrhythmias (tachycardia) 2 hypertension 3 ischemic heart disease (angina,resulting in

decreased cardiac work and reduction in oxygen demand, slowing and regularization of the heart rate)

4 myocardial infraction (increase stroke volume in some patients with obstructive cardiomyopathy)

5 else hyperthyroidism and crisis, glaucoma (timolol), splitting headache (brow ague), cardiomyopathy

Page 19: Adrenoceptor antagonist drugs Department of pharmacology Zhu ling ( 朱玲 ) 2010.3

β β receptor antagonistreceptor antagonist

Adverse reaction

1 alimentary tract and CNS effects

2 worsening of preexisting bronchial asthma

3 heart inhibition , peripheral blood vessels spasm

4 rebound phenomenon (rapid withdraw can lead to supersensitivity of receptor)